|
| Press Releases |
|
 |
|
| Friday, April 26, 2019 |
|
|
Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER |
| Sanofi delivered strong Q1 2019 business EPS growth of 9.4% at CER. more info >> |
|
| Thursday, February 7, 2019 |
|
|
Sanofi delivers 2018 business EPS growth of 5.1% at CER |
| Sanofi announced the 2018 fourth-quarter and full-year results. more info >> |
|
| Wednesday, February 7, 2018 |
|
|
Sanofi Delivers 2017 Business EPS in line with Guidance |
| Sanofi Delivers 2017 Business EPS in line with Guidance more info >> |
|
| Monday, January 22, 2018 |
|
|
Sanofi to Acquire Bioverativ for $11.6 Billion |
| Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ for $105 per share in cash, representing an equity value of approximately $11.6 billion (on a fully diluted basis). The transaction was unanimously approved by both the Sanofi and Bioverativ Boards of Directors. more info >> |
|
| Friday, October 6, 2017 |
|
|
Sanofi: Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent(R) (alirocumab) |
| Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent injunction in the dispute concerning Amgen's asserted patent claims for antibodies targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). This ruling means that Sanofi and Regeneron will continue marketing, selling and manufacturing Praluent(R) (alirocumab) injection in the U.S. more info >> |
|
| Thursday, February 13, 2014 |
|
|
A*STAR, NUS and NUH Join Forces to Understand Immune Erosion in Elderly |
| A*STAR's Singapore Immunology Network (SIgN) signed a three-year partnership with the National University of Singapore (NUS), National University Hospital (NUH) and Sanofi Pasteur to embark on a Phase IV clinical trial to understand age-related loss of immunity, known as immunosenescence, in elderly. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
MHIEC Receives Order to Refurbish the Hiroshima Naka Waste to Energy Plant
Aug 20, 2019 10:09 HKT/SGT
|
|
|
IVD Medical announces 2019 Interim Results; Profit surges 897.3% to RMB 350 million
Aug 20, 2019 09:55 HKT/SGT
|
|
|
Four HKTDC August fairs and ICMCM draw to a close 
Aug 19, 2019 20:00 HKT/SGT
|
|
|
Sino-US trade talks resume but outcome still uncertain
Aug 19, 2019 20:00 HKT/SGT
|
|
|
Student Group Looks to Hold Night Festival to Help Increase Tourism to Kouri Island, Okinawa
Aug 19, 2019 18:00 HKT/SGT
|
|
|
JCB partners with EVO Payments to enable JCB card acceptance for merchants in the UK and Ireland
Aug 19, 2019 16:00 HKT/SGT
|
|
|
New Combustor Center for Manufacturing Aero Engine Parts to be Established within MHI's Nagasaki Shipyard & Machinery Works
Aug 19, 2019 11:49 HKT/SGT
|
|
|
China Medical System Holdings Limited 2019 Interim Results Announcement
Aug 16, 2019 21:19 HKT/SGT
|
|
|
Toyota Yaris WRC Ready to Master the Varied Roads of Germany
Aug 16, 2019 19:13 HKT/SGT
|
|
|
Hengdeli Announces 2019 Interim Results
Aug 16, 2019 19:12 HKT/SGT
|
|
|
Fujitsu Develops AI Disaster Mitigation Technology to Predict River Flooding with Limited Data
Aug 16, 2019 13:10 HKT/SGT
|
|
|
ULVAC Launches Revolutionary PZT Piezoelectric Thin-film Process Technology and HVM Solution for MEMS Sensors/Actuators
Aug 16, 2019 13:00 HKT/SGT
|
|
|
Fourth Belt and Road Summit held in Hong Kong next month
Aug 16, 2019 12:00 HKT/SGT
|
|
|
HKTDC welcomes the Government's new economic relief measures
Aug 15, 2019 20:30 HKT/SGT
|
|
|
Duiba Group Announces 2019 Interim Results
Aug 15, 2019 20:01 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
